Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Kristina Gill

3 papers in the library · 47 citations · publishing 2020-2021

Papers

Datura quids at Pinwheel Cave, California, provide unambiguous confirmation of the ingestion of hallucinogens at a rock art site.

Proceedings of the National Academy of Sciences of the United States of America December 8, 2020 David W Robinson, Kelly Brown, Moira Mcmenemy et al. 40 citations

At a California rock art site called Pinwheel Cave, fibrous quids found in the ceiling alongside a painting possibly depicting Datura flowers were analyzed. Chemical tests detected hallucinogenic alkaloids scopolamine and atropine in the quids, and microscopic analysis identified most as Datura wrightii. Three-dimensional analysis showed the quids were chewed, indicating consumption of the plant in the cave beneath the paintings. Archaeological evidence and dating show the site was used from the Late Prehistoric through Colonial periods for various activities. The findings suggest the rock painting represents the plant and codified communal rituals involving this powerful entheogen, providing the first unambiguous evidence of hallucinogen consumption at a rock art site and challenging prior assumptions about trance and rock art imagery.

Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances

ACS Chemical Neuroscience May 12, 2020 Kodye L. Abbott, Kristina Gill, Patrick Flannery et al. 7 citations

Regulations intended to prevent harm and addiction from substances like cannabis, MDMA, LSD, and psilocybin also create major barriers for scientists trying to study these drugs. The authors argue that modifying current drug scheduling to reclassify illicit substances would allow extensive testing in research settings, potentially advancing life-saving research.

Neurological and Related Adverse Events Associated with Pharmacokinetic Interactions of Illicit Substances of Fungal Origin with Clinical Drugs

July 15, 2021 Julia M. Salamat, Kodye L. Abbott, Patrick Flannery et al.

This chapter reviews psychoactive illicit substances of fungal origin, focusing on psilocybin, the hallucinogenic compound in 'magic mushrooms' from genera such as Conocybe, Gymnopilus, Panaeolus, Pluteus, and Psilocybe. It describes neurological and related adverse events that can result from pharmacokinetic interactions between these fungal substances and clinical drugs in humans. The chapter also outlines directions for future research to better understand the underlying mechanisms of these adverse events.